Author:
McNeill Paul M.,Kerridge Ian H.,Arciuli Catherine,Henry David A.,Macdonald Graham J.,Day Richard O.,Hill Suzanne R.
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Health(social science)
Reference31 articles.
1. Australian Pharmaceutical Manufacturers’ Association (2000). Edition 13 Code of Conduct of the Australian Pharmaceutical Manufacturers’ Association, 1999 December (effective 1 January 2000) with amendments (adopted September 2000). Deakin, ACT, Australia: Medicines Australia.
2. Blumenthal, D. (2004). Doctors and drug companies. New England Journal of Medicine, 351(18), 1885–1890, October 28.
3. Brody, H. (2005). The company we keep: Why physicians should refuse to see pharmaceutical representatives. Annals of Family Medicine, 3(1), 82–85, January 1.
4. Caamano, F., Figueiras, A., & Gestal-Otero, J. J. (2002). Influence of comercial information on prescription quantity in primary care. European Journal of Public Health, 12, 187–191.
5. Collier, J., & Iheanacho, I. (2002). The pharmaceutical industry as informant. Lancet, 360, 1405–1409.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献